Cargando…

Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin

The global prevalence of type 2 diabetes (T2D) is expected to exceed 642 million people by 2040. Metformin is a widely used biguanide T2D therapy, associated with rare but serious events of lactic acidosis, in particular with predisposing conditions (e.g., renal failure or major surgery). Imeglimin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theurey, Pierre, Vial, Guillaume, Fontaine, Eric, Monternier, Pierre‐Axel, Fouqueray, Pascale, Bolze, Sébastien, Moller, David E., Hallakou‐Bozec, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915386/ https://www.ncbi.nlm.nih.gov/pubmed/35274817 http://dx.doi.org/10.14814/phy2.15151

Ejemplares similares

Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
por: Hallakou‐Bozec, Sophie, et al.
Publicado: (2020)

Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity
por: Theurey, Pierre, et al.
Publicado: (2022)

Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action
por: Hallakou-Bozec, Sophie, et al.
Publicado: (2021)

Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration
por: Detaille, D, et al.
Publicado: (2016)

Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF rats
por: Hallakou‐Bozec, Sophie, et al.
Publicado: (2020)

Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects
por: Fouqueray, Pascale, et al.
Publicado: (2022)

The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells
por: Vial, Guillaume, et al.
Publicado: (2021)

Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b study
por: Fouqueray, Pascale, et al.
Publicado: (2021)

Therapeutic potential of deuterium‐stabilized (R)‐pioglitazone—PXL065—for X‐linked adrenoleukodystrophy
por: Monternier, Pierre‐Axel, et al.
Publicado: (2022)

Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis
por: Gluais‐Dagorn, Pascale, et al.
Publicado: (2021)

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
por: Fouqueray, Pascale, et al.
Publicado: (2013)

Metformin-associated lactic acidosis in an intensive care unit
por: Peters, Nicolas, et al.
Publicado: (2008)

Short‐and long‐term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome
por: Lachaux, Marianne, et al.
Publicado: (2020)

Metformin-Associated Lactic Acidosis
por: Suh, Sunghwan
Publicado: (2015)

Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
por: Jacques, Vincent, et al.
Publicado: (2021)

Metformin-Induced Lactic Acidosis: A Question of Time
por: Bellefroid, Céline, et al.
Publicado: (2020)

Effects of the anti-diabetic imeglimin in hyperglycemic mice with septic shock
por: Wagner, F, et al.
Publicado: (2012)

Metformin-associated Lactic Acidosis: An Unexpected Scenario
por: Asif, Samia, et al.
Publicado: (2019)

SUN-683 Was Metformin the Culprit for This Lactic Acidosis?
por: Vemparala, Pranathi, et al.
Publicado: (2020)

A Case of Metformin-Associated Lactic Acidosis
por: Mahmood, Rabia, et al.
Publicado: (2023)

Metformin-induced lactic acidosis: a case series
por: Silvestre, Joana, et al.
Publicado: (2007)

Metformin-Associated Acute Kidney Injury and Lactic Acidosis
por: Arroyo, David, et al.
Publicado: (2011)

Metformin-induced lactic acidosis: no one left behind
por: Vecchio, Sarah, et al.
Publicado: (2011)

Outcome of severe lactic acidosis associated with metformin accumulation
por: Friesecke, Sigrun, et al.
Publicado: (2010)

Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
por: Kim, Min Ju, et al.
Publicado: (2015)

Lactic acidosis and the relationship with metformin usage: Case reports
por: Huang, Weiyi, et al.
Publicado: (2016)

Metformin-Induced Lactic Acidosis: A Case Study
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Metformin-Associated Lactic Acidosis: A Case Report
por: Umeda, Takehide, et al.
Publicado: (2018)

A Unique Case of Metformin-Associated Lactic Acidosis
por: Gershkovich, Benjamin, et al.
Publicado: (2018)

Succinate and the shortcut to the cure of metformin-induced lactic acidosis
por: Protti, Alessandro
Publicado: (2018)

Combined metformin-associated lactic acidosis and euglycemic ketoacidosis
por: Schwetz, Verena, et al.
Publicado: (2017)

A Case Report on Metformin-Associated Lactic Acidosis
por: Rai, Harpreet K, et al.
Publicado: (2020)

Cardiopulmonary arrest from metformin-induced lactic acidosis
por: Pell, Robert, et al.
Publicado: (2022)

Vildagliptin/metformin: Lactic acidosis and hypoglycaemia: case report
Publicado: (2022)

Metformin: When Should We Fear Lactic Acidosis?
por: Di Mauro, Stefania, et al.
Publicado: (2022)

Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24‐week, randomized, double‐blind, placebo‐controlled, dose‐ranging phase 2b trial
por: Dubourg, Julie, et al.
Publicado: (2021)

Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas
por: Chu, Patricia Y., et al.
Publicado: (2020)

Metformin-associated lactic acidosis: risk factors and prognostic factors
por: Falco, V Di, et al.
Publicado: (2013)

Lactic acidosis secondary to metformin overdose: a case report
por: Timbrell, Simon, et al.
Publicado: (2012)

Extreme lactic acidosis type B associated with metformin treatment
por: Pikwer, Andreas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ipg1vta3ch1pbm5tq9ievvjna